Related references
Note: Only part of the references are listed.The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism
Olivier Calvayrac et al.
EMBO MOLECULAR MEDICINE (2017)
Rho GTPases: Anti- or pro-neoplastic targets?
I. Zandvakili et al.
ONCOGENE (2017)
CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis
Lei Jin et al.
ONCOTARGET (2017)
Hypoxia Selectively Enhances Integrin α5β1 Receptor Expression in Breast Cancer to Promote Metastasis
Julia A. Ju et al.
MOLECULAR CANCER RESEARCH (2017)
Expression of Rho GTPases family in melanoma cells and its influence on cytoskeleton and migration
Si-Jian Wen et al.
ONCOTARGET (2017)
Dual inhibition of histone deacetylases and phosphoinositide 3-kinases: effects on Burkitt lymphoma cell growth and migration
Ana Carolina dos Santos Ferreira et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition
E. Bousquet et al.
ONCOGENE (2016)
Implications of Hypoxia in Breast Cancer Metastasis to Bone
Daniele M. Gilkes
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border
Beatriz Marcos-Ramiro et al.
JOURNAL OF CELL BIOLOGY (2016)
Intrinsic protective mechanisms of the neuron-glia network against glioma invasion
Yasuo Iwadate et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma
Weihao Chen et al.
PLOS ONE (2016)
RhoB upregulation leads to either apoptosis or cytostasis through differential target selection
Laura A. Marlow et al.
ENDOCRINE-RELATED CANCER (2015)
The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors
Audrey Delmas et al.
ONCOTARGET (2015)
Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer
Yonggang Tan et al.
ONCOTARGET (2015)
Critical functions of RhoB in support of glioblastoma tumorigenesis
Yufang Ma et al.
NEURO-ONCOLOGY (2015)
p300 cooperates with c-Jun and PARP-1 at the p300 binding site to activate RhoB transcription in NSC126188-mediated apoptosis
Bo-Kyung Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
RhoB Determines Tumor Aggressiveness in a Murine EGFRL858R-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
Olivier Calvayrac et al.
CLINICAL CANCER RESEARCH (2014)
RhoB Promotes Cancer Initiation by Protecting Keratinocytes from UVB-Induced Apoptosis but Limits Tumor Aggressiveness
Nicolas Meyer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner
Diego Luis-Ravelo et al.
MOLECULAR ONCOLOGY (2014)
Activation of the RhoB Signaling Pathway by Thyroid Hormone Receptor β in Thyroid Cancer Cells
Sayaka Ichijo et al.
PLOS ONE (2014)
RhoB Differentially Controls Akt Function in Tumor Cells and Stromal Endothelial Cells during Breast Tumorigenesis
Shiva Kazerounian et al.
CANCER RESEARCH (2013)
Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration
P. J. Bhavsar et al.
ONCOGENE (2013)
Expression Loss and Revivification of RhoB Gene in Ovary Carcinoma Carcinogenesis and Development
Yingwei Liu et al.
PLOS ONE (2013)
Rnd3 induces stress fibres in endothelial cells through RhoB
Undine Gottesbuehren et al.
BIOLOGY OPEN (2013)
RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor
Claire Medale-Giamarchi et al.
BREAST CANCER RESEARCH (2013)
RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer
Prakash Vishnu et al.
GYNECOLOGIC ONCOLOGY (2012)
RhoB controls endothelial cell morphogenesis in part via negative regulation of RhoA
Grant A. Howe et al.
VASCULAR CELL (2012)
The activation of p38 MAPK primarily contributes to UV-induced RhoB expression by recruiting the c-Jun and p300 to the distal CCAAT box of the RhoB promoter
Jiwon Ahn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells
Ming Liu et al.
FEBS LETTERS (2011)
A distinct role of RhoB in gastric cancer suppression
Jitao Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
Celine Sabatel et al.
PLOS ONE (2011)
Rac and Rho GTPases in cancer cell motility control
Matteo Parri et al.
CELL COMMUNICATION AND SIGNALING (2010)
RhoB enhances migration and MMP1 expression of prostate cancer DU145
Misao Yoneda et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
αvβ3/αvβ5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
Nicolas Skuli et al.
CANCER RESEARCH (2009)
Rho isoforms have distinct and specific functions in the process of epithelial to mesenchymal transition in renal proximal tubular cells
Nicol Hutchison et al.
CELLULAR SIGNALLING (2009)
RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells
Dong-Myung Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
In vivo restoration of RhoB expression leads to ovarian tumor regression
B. Couderc et al.
CANCER GENE THERAPY (2008)
Rho GTPases in cancer cell biology
Francisco M. Vega et al.
FEBS LETTERS (2008)
Mammalian Rho GTPases:: new insights into their functions from in vivo studies
Sarah J. Heasman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Regulation of glioblastoma cell invasion by PKCι and RhoB
R. M. Baldwin et al.
ONCOGENE (2008)
RhoB regulates PDGFR-β trafficking and signaling in vascular smooth muscle cells
Minzhou Huang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Epigenetic regulation of RhoB loss of expression in lung cancer
Julien Mazieres et al.
BMC CANCER (2007)
ROCK I-mediafed activation of NF-κB by RhoB
Pedro L. Rodriguez et al.
CELLULAR SIGNALLING (2007)
Rho GTPases: functions and association with cancer
Saskia I. J. Ellenbroek et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line
Naohito Sato et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter
F. L. Delarue et al.
ONCOGENE (2007)
Up-regulation of RhoB by glucocorticoids and its effects on the cell proliferation and NF-κB transcriptional activity
Yu-Xia Chen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway
Chun-Chieh Wang et al.
CANCER RESEARCH (2006)
Activation of RhoB by hypoxia controls hypoxia-inducible factor-1 alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells
N Skuli et al.
CANCER RESEARCH (2006)
RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling
B Canguilhem et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer
E Winquist et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2005)
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo
JY Pillé et al.
MOLECULAR THERAPY (2005)
Loss of RhoB expression in human lung cancer progression
J Mazieres et al.
CLINICAL CANCER RESEARCH (2004)
Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors
CL Ho et al.
CANCER RESEARCH (2004)
RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane
E Sandilands et al.
DEVELOPMENTAL CELL (2004)
Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase
M Wherlock et al.
JOURNAL OF CELL SCIENCE (2004)
Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility
AP Wheeler et al.
EXPERIMENTAL CELL RESEARCH (2004)
Cyclin B1 is a critical target of RhoB in the cell suicide program triggered by farnesyl transferase inhibition
U Kamasani et al.
CANCER RESEARCH (2004)
Akt mediates ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis
K Jiang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer
S Rao et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts
I Ader et al.
ONCOGENE (2003)
A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells
L Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development
I Adini et al.
GENES & DEVELOPMENT (2003)
Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line
SW Wang et al.
ONCOGENE (2003)
Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer
SRD Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Farnesyl transferase inhibitor SCH66336 is cytostatic, pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells
KSM Smalley et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma
A Horiuchi et al.
LABORATORY INVESTIGATION (2003)
Phase II study of the farnesyl transferase inhibitor r115777 in patients with advanced non-small-cell lung cancer
AA Adjei et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma
SJ Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Farnesyl thiosalicylic acid chemosensitizes human melanoma in vivo
J Halaschek-Wiener et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters
G Fritz et al.
BRITISH JOURNAL OF CANCER (2002)
RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death
I Ader et al.
ONCOGENE (2002)
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan
S Sharma et al.
ANNALS OF ONCOLOGY (2002)
The expression of Rho proteins decreases with human brain tumor progression: Potential tumor markers
MA Forget et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells
AX Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage
AX Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors
AX Liu et al.
FEBS LETTERS (2000)
RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors
AX Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice
Z Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Regulation of endocytic traffic by Rho family GTPases
S Ellis et al.
TRENDS IN CELL BIOLOGY (2000)
Ras-related GTPase RhoB forces alkylation-induced apoptotic cell death
G Fritz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
